Publicacions en què col·labora amb Christoph U. Correll (11)

2025

  1. Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses

    European Neuropsychopharmacology, Vol. 90, pp. 1-15

2024

  1. Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study

    Psychiatry Research, Vol. 342

2023

  1. The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications

    Neuroscience and Biobehavioral Reviews, Vol. 149

  2. Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults

    Journal of Affective Disorders, Vol. 326, pp. 249-261

2022

  1. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A)

    Journal of Affective Disorders, Vol. 299, pp. 367-376

  2. The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic

    Journal of Affective Disorders, Vol. 299, pp. 393-407

  3. The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations

    European Neuropsychopharmacology, Vol. 59, pp. 45-55

2015

  1. Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives

    European Neuropsychopharmacology, Vol. 25, Núm. 10, pp. 1513-1531

2014

  1. Second-generation antipsychotic use in children and adolescents: A six-month prospective cohort study in drug-naïve patients

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 53, Núm. 11, pp. 1179-1190.e4

2011

  1. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons

    European Neuropsychopharmacology, Vol. 21, Núm. 8, pp. 621-645

2009

  1. Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns

    European Neuropsychopharmacology, Vol. 19, Núm. 9, pp. 629-635